Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital

Site:	Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Address:
City:	Amsterdam
State:
Zip:	1066 CX
Country:	Netherlands

Phase	Trial	Trial Status	Site Status	Drug	NCT#
3	Masitinib 2nd Line versus Sunitinib in Advanced GIST	Unknown	Active	Masitinib or Sunitinib	NCT01694277
2	A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST) (ALT GIST)	Unknown	Active	Imatinib + Regorafenib	NCT02365441
3	Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate	Terminated	Closed	Imatinib	NCT00956072
3	Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST	Recruiting	Active	Imatinib	NCT02413736
3	A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib (intrigue)	Active, not recruiting	Active	QINLOCK Ripretinib DCC-2618 SUTENT Sunitinib	NCT03673501